Received Sep 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | IM |
stomach discomfort; Injection sight soreness; muscle soreness throughout my body; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach discomfort), VACCINATION SITE PAIN (Injection sight soreness), MYALGIA (muscle soreness throughout my body) and VOMITING (vomiting) in a 66-year-old female patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. No Medical History information was reported. On 14-Sep-2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) 1 dosage form. On 14-Sep-2025, the patient experienced ABDOMINAL DISCOMFORT (stomach discomfort), VACCINATION SITE PAIN (Injection sight soreness), MYALGIA (muscle soreness throughout my body) and VOMITING (vomiting). At the time of the report, ABDOMINAL DISCOMFORT (stomach discomfort), VACCINATION SITE PAIN (Injection sight soreness), MYALGIA (muscle soreness throughout my body) and VOMITING (vomiting) was resolving. No concomitant medication was reported. The patient had injection site soreness, muscle soreness throughout her body, stomach discomfort, and vomiting. It was unknown if the patient experienced any additional symptoms or events. Reporter causality was not provided. No treatment medication was reported.